Clinical trials for a new coronavirus vaccine approved at a Seattle research institute
[div class="excerpt"]Clinical trials for a new coronavirus vaccine approved at a Seattle research institute
The clinical trial for a novel coronavirus vaccine at a Seattle research facility has been approved, and people are being recruited to register as test subjects.
Researchers at the Kaiser Permanente Washington Health Research Institute were cleared on Monday to begin a clinical trial and have begun recruiting potential trial volunteers.
Researchers are looking for 45 people between the ages of 18 and 55. The trial will begin once the first volunteers pass a screening and physical examination, said Dr. Lisa Jackson, a senior investigator at the institute.
The vaccine for the virus known as SARS-CoV-2, and the subsequent disease called COVID-19, was developed by Massachusetts-based biotechnology company Moderna, which is one of many companies working to create a vaccine.
The trial subjects will receive two doses 28 days apart and return to the research institute for follow-up visits, with the last visit being a year after the first vaccination, Jackson said.
More: https://www.seattletimes.com/seattle-news/health/clinical-trials-for-a-new-coronavirus-vaccine-approved-at-a-seattle-research-institute/
= new reply since forum marked as read
